Respiratory Medicine, Allergology, and Palliative Medicine
751 – 800 of 1369
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases
(
- Contribution to journal › Article
-
Mark
Korsallergi mellan penicilliner och övriga betalaktam-antibiotika - Risken är betydligt mindre än man tidigare trott.
(
- Contribution to journal › Article
-
Mark
The Swedish CArdioPulmonary BioImage Study: objectives and design.
(
- Contribution to journal › Article
-
Mark
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
(
- Contribution to journal › Article
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
-
Mark
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
(
- Contribution to journal › Article
-
Mark
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.
(
- Contribution to journal › Article
-
Mark
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma.
(
- Contribution to journal › Scientific review
-
Mark
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation.
(
- Contribution to journal › Article
-
Mark
Obesity and asthma: current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article
-
Mark
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
(
- Contribution to journal › Article
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review
-
Mark
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
(
- Contribution to journal › Article
-
Mark
IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
(
- Contribution to journal › Article
-
Mark
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
(
- Contribution to journal › Article
-
Mark
End-of-life care in oxygen-dependent COPD and cancer: a national population-based study.
(
- Contribution to journal › Letter
-
Mark
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
(
- Contribution to journal › Article
-
Mark
Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo.
(
- Contribution to journal › Article
-
Mark
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
(
- Contribution to journal › Article
-
Mark
Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis.
(
- Contribution to journal › Article
-
Mark
Pulmonary Retransplantation in the Nordic Countries.
(
- Contribution to journal › Article
-
Mark
Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.
(
- Contribution to journal › Article
-
Mark
Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
(
- Contribution to journal › Article
-
Mark
The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
(
- Contribution to journal › Article
-
Mark
A score to predict short-term risk of COPD exacerbations (SCOPEX).
(
- Contribution to journal › Article
-
Mark
Relationship between Change in Lung Density and Long-Term Progression of Lung Function.
(
- Contribution to journal › Letter
-
Mark
Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalis.
(
- Contribution to journal › Article
-
Mark
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Guidance for the regulatory status of allergen extracts in clinical trials.
(
- Contribution to journal › Letter
-
Mark
A new approach to assess COPD by identifying lung function break-points.
(
- Contribution to journal › Article
-
Mark
The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden.
(
- Contribution to journal › Article
-
Mark
The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used
(
- Contribution to journal › Article
-
Mark
Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.
(
- Contribution to journal › Article
-
Mark
Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines.
(
- Contribution to journal › Article
-
Mark
The management of chronic breathlessness in patients with advanced and terminal illness.
(
- Contribution to journal › Scientific review
-
Mark
Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units
(
- Contribution to journal › Article
-
Mark
Chronic Obstructive Pulmonary Disease Is Common in Never-smoking Patients with Primary Sjögren Syndrome.
(
- Contribution to journal › Article
-
Mark
Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control
(
- Contribution to journal › Article
-
Mark
Antifungals in severe asthma
(
- Contribution to journal › Scientific review
-
Mark
Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptides.
(
- Contribution to journal › Article
-
Mark
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Effects of Opioids on Breathlessness and Exercise Capacity in Chronic Obstructive Pulmonary Disease: A Systematic Review.
2015) In Annals of the American Thoracic Society(
- Contribution to journal › Scientific review
-
Mark
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen.
(
- Contribution to journal › Article
-
Mark
Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.
(
- Contribution to journal › Article
-
Mark
Exercise and asthma: an overview.
(
- Contribution to journal › Scientific review
-
Mark
Application of nitric oxide measurements in clinical conditions beyond asthma.
(
- Contribution to journal › Article
-
Mark
Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
2015) In Pediatric Pulmonology(
- Contribution to journal › Article
-
Mark
Outcome measurement of refractory breathlessness: endpoints and important differences.
2015) In Current Opinion in Supportive and Palliative Care(
- Contribution to journal › Article